Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.4280
Dollar change
-0.0077
Percentage change
-1.77
%
Index- P/E- EPS (ttm)-0.55 Insider Own12.32% Shs Outstand16.98M Perf Week-14.40%
Market Cap7.27M Forward P/E- EPS next Y-0.53 Insider Trans0.00% Shs Float14.89M Perf Month-27.70%
Income-7.29M PEG- EPS next Q-0.23 Inst Own9.45% Short Float1.75% Perf Quarter-30.96%
Sales9.00M P/S0.81 EPS this Y14.47% Inst Trans47.78% Short Ratio2.43 Perf Half Y-66.17%
Book/sh0.31 P/B1.38 EPS next Y18.46% ROA-47.72% Short Interest0.26M Perf Year-61.09%
Cash/sh0.20 P/C2.16 EPS next 5Y- ROE-107.64% 52W Range0.37 - 1.86 Perf YTD-30.61%
Dividend Est.- P/FCF- EPS past 5Y45.52% ROI-150.56% 52W High-76.99% Beta0.07
Dividend TTM- Quick Ratio1.63 Sales past 5Y83.23% Gross Margin22.95% 52W Low16.30% ATR (14)0.06
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM22.10% Oper. Margin-150.32% RSI (14)35.87 Volatility9.96% 12.32%
Employees55 Debt/Eq0.26 Sales Y/Y TTM-53.31% Profit Margin-81.00% Recom1.00 Target Price2.25
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q70.94% Payout- Rel Volume0.58 Prev Close0.44
Sales Surprise14.85% EPS Surprise70.97% Sales Q/Q-83.07% EarningsFeb 08 AMC Avg Volume107.30K Price0.43
SMA20-15.33% SMA50-24.74% SMA200-56.48% Trades Volume62,574 Change-1.77%
Date Action Analyst Rating Change Price Target Change
Feb-12-21Initiated ROTH Capital Buy $24
Jan-14-21Reiterated H.C. Wainwright Buy $18 → $14
Dec-18-20Reiterated H.C. Wainwright Buy $20 → $12
Jul-20-20Reiterated H.C. Wainwright Buy $18 → $22
Jul-02-20Initiated H.C. Wainwright Buy $18
Nov-14-16Reiterated Maxim Group Buy $8 → $6
May-13-16Reiterated Maxim Group Buy $13 → $9
Oct-08-15Reiterated Maxim Group Buy $9 → $13
May-26-15Initiated The Benchmark Company Speculative Buy $5
Feb-10-15Reiterated Maxim Group Buy $7 → $9
Mar-18-24 09:00AM
Mar-14-24 10:00AM
Feb-21-24 09:40AM
Feb-10-24 08:48AM
Feb-09-24 06:17AM
05:40PM Loading…
Feb-08-24 05:40PM
04:40PM
04:05PM
Feb-05-24 01:00PM
Feb-02-24 04:15PM
Jan-31-24 08:00AM
Dec-14-23 08:00AM
Dec-12-23 08:10AM
Dec-07-23 09:55PM
04:55PM
04:05PM Loading…
04:05PM
Dec-05-23 08:30AM
Nov-28-23 08:30AM
Nov-16-23 08:30AM
Nov-09-23 09:15AM
Sep-14-23 09:00AM
Sep-06-23 09:00AM
Aug-29-23 09:00AM
Aug-23-23 09:30AM
Aug-10-23 04:56PM
04:05PM
Aug-08-23 08:15AM
Aug-07-23 11:00AM
Jul-27-23 06:24PM
Jul-18-23 10:00AM
07:15AM Loading…
Jul-13-23 07:15AM
Jun-08-23 11:00AM
May-16-23 11:53AM
May-11-23 04:56PM
04:05PM
May-03-23 03:00PM
Apr-07-23 12:00PM
Mar-29-23 09:00AM
Mar-22-23 09:35AM
Feb-15-23 12:00PM
Feb-12-23 10:43AM
Feb-10-23 09:34AM
Feb-09-23 04:05PM
Feb-02-23 10:00AM
Jan-05-23 09:45AM
Dec-22-22 10:52AM
Dec-16-22 05:32AM
Dec-14-22 04:10PM
Dec-12-22 10:00AM
Nov-10-22 09:25AM
Nov-09-22 06:25PM
Nov-08-22 07:05PM
Oct-24-22 09:30AM
Oct-10-22 11:19AM
09:45AM
Sep-30-22 09:00AM
Sep-08-22 10:00AM
Sep-07-22 12:00PM
Sep-06-22 08:00AM
Aug-31-22 06:25PM
Aug-19-22 09:45AM
Aug-17-22 09:29AM
06:15AM
Aug-11-22 06:55PM
04:10PM
Aug-10-22 05:15PM
09:30AM
09:13AM
Aug-09-22 11:30AM
08:15AM
Aug-08-22 04:05PM
01:15PM
Aug-05-22 11:37AM
Aug-04-22 10:43AM
09:16AM
08:15AM
Aug-03-22 09:38AM
08:41AM
Aug-02-22 02:14PM
01:02PM
08:03AM
Jul-25-22 08:30AM
Jul-22-22 10:00AM
Jun-29-22 10:00AM
Jun-21-22 09:18AM
Jun-06-22 11:30AM
May-12-22 06:25PM
04:05PM
May-09-22 10:00AM
Apr-06-22 09:00AM
Mar-23-22 12:00PM
Mar-14-22 08:00AM
Mar-10-22 10:00AM
Feb-24-22 05:50PM
Feb-22-22 08:00AM
Feb-17-22 09:00AM
Feb-15-22 09:55AM
Feb-10-22 06:05PM
04:05PM
Feb-07-22 09:15AM
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.